Education
About Us
Working with TipRanks
Follow Us
Lepu Biopharma Co. Ltd. Class H (HK:2157)
:2157
Comparison Results
Lepu Biopharma Co. Ltd. Class H
HK$7.23
HK$14.55B
―
99.72%
0 Buy
0 Hold
0 Sell
Hold
Ascletis Pharma, Inc.
HK$10.50
HK$10.49B
―
615.79%
1 Buy
1 Hold
0 Sell
Moderate Buy
Keymed Biosciences, Inc.
HK$71.25
HK$21.20B
―
67.54%
1 Buy
0 Hold
0 Sell
Moderate Buy
CARsgen Therapeutics Holdings Ltd.
HK$19.30
HK$11.93B
―
279.79%
0 Buy
0 Hold
0 Sell
Moderate Sell
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$25.56
HK$10.67B
70.94
236.19%
0 Buy
0 Hold
0 Sell
Hold
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H
HK$14.63
HK$13.20B
―
91.17%
0 Buy
0 Hold
0 Sell
Hold
Performance Comparison
HK:2157
Lepu Biopharma Co. Ltd. Class H
7.15
4.07
132.14%
HK:1672
Ascletis Pharma, Inc.
9.52
8.22
632.31%
HK:2162
Keymed Biosciences, Inc.
70.45
29.45
71.83%
HK:2171
CARsgen Therapeutics Holdings Ltd.
18.04
13.80
325.47%
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
25.08
17.92
250.28%
HK:1541
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H
12.56
6.55
108.99%